510(k) K031373
K031373 is an FDA 510(k) premarket notification submitted by Insulet Corp. for the device "IXL DIABETES MANAGEMENT SYSTEM". The FDA issued a decision of Substantially Equivalent on Dec 19, 2003. The device falls under product code LZG (Pump, Infusion, Insulin), a Class II device regulated under 21 CFR 880.5725.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 19, 2003
- Date Received
- Apr 30, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Pump, Infusion, Insulin
- Device Class
- Class II
- Regulation Number
- 880.5725
- Review Panel
- CH
- Submission Type
- 510(k)